A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug ...

Vertex Pharmaceuticals Incorporated today announced that the U.S. Food and Drug Administration (FDA) has approved JOURNAVXtm (suzetrigine), an oral, non-opioid, highly selective NaV1.8 pain signal ...

The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.

Life Science Washington, the state’s life sciences industry association, today announced the expansion of its board of directors with the addition of nine new members, representing distinguished ...

Valmet's Shareholders' Nomination Board updates its proposal for the composition and remuneration of the Board of Directors Valmet Oyj's stock exchange release on January 27, 2025 at 2:00 p.m. EET ...

BURLINGTON, Mass. - Azenta, Inc. (NASDAQ: AZTA), a global provider of life sciences solutions, announced the election of ...

Takeda CEO Christophe Weber announced he will step down in 2026 and be replaced by Julie Kim, president of Takeda’s U.S.

Despite continued underperformance in 2024, the biotech sector enters 2025 with a brighter outlook driven by groundbreaking ...

Rocket Pharmaceuticals, Inc. (NASDAQ ... announced a recent change to its Board of Directors. The company's stock, currently trading near its 52-week low of $10.07, has faced significant headwinds ...

The activist investor Ananym Capital Management had plans to nominate as many as six directors to the board at Henry Schein, Reuters reported earlier in January, arguing the company needs to start ...

The FDA approves a new type of nonopioid painkiller for acute pain. And NBC News speaks to transgender service members who ...